Summary : Novartis has signed an initial agreement with Carisma Therapeutics, a biopharmaceutical pioneer in engineered macrophage-based therapeutics, to manufacture the HER…
Synopsis : Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery…
Summary : The Karnataka Cabinet on 11 March 2022 has cleared the implementation of Centrally-sponsored Pradhan Mantri Kisan Urja Suraksha Evam Utthaan…
Synopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…
Synopsis : Valneva’s single-shot chikungunya vaccine candidate, VLA1553, offered a very high level of seroprotection in all adults, including the elderly. The…
Summary : The safety and efficacy of fezolinetant is being evaluated in the Phase III trial of over 1,800 women seeking relief…
Summary : Trodelvy® (sacituzumab govitecan-hziy) was found to significantly reduce the risk of disease progression or death in certain breast cancer patients. Trodelvy® (sacituzumab…
Highlight Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced that Shionogi has…
Summary : 7th March 2022, Evonik has inaugurated the new Applied Technology Center in Americana (Brazil) aimed at developing modern and innovative sustainable solutions for…
Summary : With the registration of Syngenta’s PostivaTM fungicide, ornamental producers now have a powerful tool to assist manage challenging diseases like…